Erica Schwartz for CDC Director: Inside the White House Pick

The Trump administration has selected Erica Schwartz, a former deputy surgeon general and retired U.S. Coast Guard officer, to lead the Centers for Disease Control and Prevention (CDC) in an effort to stabilize the agency.

A Departure from Prior Health Priorities

The choice of Schwartz is a notable shift from previous candidates who aligned with the “Make America Healthy Again” (MAHA) movement. Unlike prior contenders, Schwartz has an extensive record of managing government vaccination programs and crisis responses.

This marks a stark contrast to the administration’s first CDC pick, Dr. Dave Weldon, whose nomination was withdrawn after it became clear his vaccine skepticism would hinder his confirmation.

Agency Upheaval and Leadership Struggles

The CDC has faced a tumultuous 12 months characterized by abrupt leadership changes and a decline in employee morale. Former director Dr. Susan Monarez, a longtime public health official, was removed from her post less than a month after confirmation following clashes with Health and Human Services (HHS) Secretary Robert F. Kennedy Jr.

Following Monarez’s departure in August, Jim O’Neill served as interim head. However, White House and HHS officials reportedly grew dissatisfied with O’Neill, citing his lack of presence at the Atlanta headquarters and poor communication skills.

The agency is currently being overseen by Jay Bhattacharya, who also serves as the director of the National Institutes of Health.

White House Oversight and Midterm Strategy

The search for a new CDC director was led by HHS chief counselor Chris Klomp following a department review ordered by White House Chief of Staff Susie Wiles in January. The goal was to find a mainstream candidate capable of winning confirmation in a divided Senate while remaining willing to work with Secretary Kennedy.

Senior officials have increasingly sought to rein in the HHS department to avoid damaging news cycles that could impact Republicans in the upcoming midterms. This includes discouraging Kennedy and his aides from publicly discussing vaccine overhauls, which are viewed as politically toxic to voters.

To further signal stability, the administration has lined up additional appointments to support Schwartz, including former Walmart executive Sean Slovenski, Texas health commissioner Jennifer Shuford, and FDA official Sara Brenner.

Mixed Reactions to the Nomination

While the candidacy has received praise on Capitol Hill, some public health experts remain skeptical. Dr. Amesh Adalja of the Johns Hopkins Center for Health Security stated that while Schwartz is well-qualified, the appointment may be “window dressing” if RFK Jr. remains in place.

Conversely, the move has sparked backlash among vaccine critics. Toby Rogers described the appointment as a “slap in the face” to the medical freedom base, while vaccine injury lawyer Aaron Siri argued that Schwartz would simply restore “business as usual” at the agency.

Secretary Kennedy has largely acquiesced to these White House-led changes. He is expected to focus his public efforts on healthier eating and lowering drug prices in the months leading up to the midterms.